Cheng-Long Han, Bao-Wen Tian, Lun-Jie Yan, Zi-Niu Ding, Hui Liu, Guo-Qiang Pan, Xiao Zhang, Xin-Chen Mao, Si-Yu Tan, Rui-Zhe Li, Dong-Xu Wang, Zhao-Ru Dong, Yu-Chuan Yan, Tao Li
BACKGROUND: The effect of age, sex, and eastern cooperative oncology group performance status (ECOG PS) on the efficacy and safety of immune checkpoint inhibitor (ICI) therapy among hepatocellular carcinoma (HCC) patients remains elusive. Thus, a meta-analysis was conducted to evaluate whether such effects exist. RESEARCH DESIGN AND METHODS: Eligible studies in PubMed, Embase, and Cochrane Library databases were retrieved. RESULTS: One-hundred-and-eleven studies involving 14,768 HCC patients were included...
April 16, 2024: Expert Review of Anticancer Therapy